跳到主要内容
Learn Motion
探索课程产品能力价格

下载 Learn Motion

用手机扫描二维码,下载 App。

App Store

扫码从 App Store 下载 Learn Motion打开商店页面

Google Play

扫码从 Google Play 下载 Learn Motion打开商店页面
登录
Learn Motion

How AI Uses DNA to Find New Medicines

1Why DNA Matters for Finding Medicines2Turning DNA Into Data a Computer Can Read3How AI Learns Patterns in DNA4From DNA Patterns to Disease Clues5From Target to Candidate Medicine6What AI Can and Cannot Do Here
From DNA Patterns to Disease Clues

Turning Associations Into a Ranked List of Targets

2 / 3
Look at the list from top to bottom. Each row is a gene or protein, and the bar beside it shows how strong the combined evidence is. That bar is not built from one association — it is built from many. Hundreds of individually weak signals get grouped by the gene they sit near, and then other evidence is folded in: is this gene active in the tissue the disease affects, is the protein it makes the sort a drug could act on. The ordering tells you where to look first. But read the bars carefully. A long bar means several independent lines of evidence agree. A short bar might mean the case is genuinely thin, or it might just mean this gene has barely been studied. So a low rank is not the same as unimportant.
0:00 / 0:00

Hundreds or thousands of associated positions may point at the same general region, and each one on its own is weak. The useful move is to combine them. AI takes the full set of associations, groups the positions that fall near the same gene, and adds other kinds of evidence — whether the gene is active in the tissue affected by the disease, whether the protein it makes is the kind a drug can act on, whether related genes are already known to matter. Each gene or protein ends up with a combined score.

Ordering by that score produces a prioritized list. The top entries are the places most worth investigating first. The confidence bars next to each entry are a compact way of showing how strong the combined evidence is: a long bar means many independent lines of evidence point the same way, a short bar means the case is thin.

Two things about this list deserve emphasis. First, the ranking is relative — it says which candidates look better than others, not that the top one is correct. Second, the score reflects the evidence available, and evidence can be uneven: a gene that has been studied a lot will usually have more supporting data than one that has barely been looked at, so a low rank can mean "little is known" rather than "unimportant."

上一页2 / 3下一页

Learn Motion

生成课程,认真学会。

运营方:Wuhan Daoyin Technology Co., Ltd.

联系我们: [email protected]
隐私政策用户服务协议

© 2026 Learn Motion